Peter Boström

Nalidixic acid-a good marker of fluoroquinolone resistance mechanisms in Escherichia coli (2025)

Microbiology spectrum

Kalinen, Sofia; Kallio, Heini; Kallonen, Teemu; Knaapila, Juha; Lamminen, Tarja; Huovinen, Pentti; Boström, Peter; Hakanen, Antti J.; Gunell, Marianne

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

High‐Sensitivity Detection of Urinary Extracellular Vesicles With Upconverting Nanoparticle‐Based Lateral Flow Immunoassay (2025)

Journal of Extracellular Biology

Islam, Md. Khirul; Mahmud, Imran; Ali, Klinton; Salminen, Teppo; Taimen, Pekka; Boström, Peter J.; Leivo, Janne; Lamminmäki, Urpo; Martiskainen, Iida

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy (2025)

World Journal of Urology

Rinderknecht, Emily; Claps, Francesco; Boström, Peter J.; Shariat, Shahrokh F.; Neuzillet, Yann; Zlotta, Alexandre R.; Trombetta, Carlo; Eckstein, Markus; Lijnen, Renee A. G.; Mertens, Laura S.; Bussani, Rossana; Burger, Maximilian; van Leenders, Geert J. L. H.; Boormans, Joost L.; Wullich, Bernd; Hartmann, Arndt; Pavan, Nicola; Pouessel, Damien; van der Kwast, Theo H.; Allory, Yves; Zuiverloon, Tahlita C. M.; Lotan, Yair; van Rhijn, Bas W. G.; Mayr, Roman

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: A Nationwide Analysis of Eligibility, Utilization, and Outcomes (2025)

Cancers

Nikulainen, Ilkka; Salminen, Antti P.; Högerman, Mikael; Seikkula, Heikki; Boström, Peter J.; The Finnish National Cystectomy Database Research Group

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Cross-cultural adaptation and psychometric validation of the Finnish version of the Expanded Prostate Cancer Index Composite-26 for patients with localised prostate cancer (2025)

Scandinavian Journal of Urology

Ettala, Otto; Bergroth, Robin; Riikonen, Jarno; Boström, Peter; Koskimäki, Juha; Kuisma, Jani; Rannikko, Antti; Vaarala, Markku; Sanda, Martin G; Santti, Henrikki

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study (2025)

BJU International

Viitala, Antti; Anttinen, Mikael; Mäkelä, Pietari; Pärssinen, Heikki; Nurminen, Pertti; Sainio, Teija; Saunavaara, Jani; Taimen, Pekka; Sequeiros, Roberto Blanco; Boström, Peter J.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Long‐Term Risk of Clinically Significant Prostate Cancer in Biopsy‐Negative Patients With Baseline Biparametric Prostate MRI (2025)

Journal of Magnetic Resonance Imaging

Parhiala, Laura; Knaapila, Juha; Jambor, Ivan; Verho, Janne; Syvänen, Kari; Aronen, Hannu; Boström, Peter; Ettala, Otto

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Improved diagnostic performance of a phage display antibody-assisted intact free PSA assay as used in the four kallikrein concept applied to the IMPROD/multi-IMPROD study (2025)

Clinica Chimica Acta

Khan, Md. Ferdhos L.; Perez, Ileana M.; Kekki, Henna; Taimen, Pekka; Boström, Peter J.; Jambor, Ivan; Ettala, Otto; Pahikkala, Tapio; Pettersson, Kim

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Time to abandon routine urine analysis prior to Bacillus Calmette–Guérin administration in asymptomatic patients (2025)

BJUI COMPASS

Nummi, Antti; Nurminen, Pertti; Kesti, Olli; Högerman, Mikael; Ettala, Otto; Boström, Peter J.; Kaipia, Antti; Sairanen, Jukka; Järvinen, Riikka

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer (2025)

European Urology Open Science

Anttinen, Mikael; Mäkelä, Pietari; Nurminen, Pertti; Pärssinen, Heikki; Malaspina, Simona; Sainio, Teija; Högerman, Mikael; Taimen, Pekka; Blanco Sequeiros, Roberto; Boström, Peter J.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Peter

Boström

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Nalidixic acid-a good marker of fluoroquinolone resistance mechanisms in Escherichia coli (2025)

High‐Sensitivity Detection of Urinary Extracellular Vesicles With Upconverting Nanoparticle‐Based Lateral Flow Immunoassay (2025)

Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy (2025)

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: A Nationwide Analysis of Eligibility, Utilization, and Outcomes (2025)

Cross-cultural adaptation and psychometric validation of the Finnish version of the Expanded Prostate Cancer Index Composite-26 for patients with localised prostate cancer (2025)

Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study (2025)

Long‐Term Risk of Clinically Significant Prostate Cancer in Biopsy‐Negative Patients With Baseline Biparametric Prostate MRI (2025)

Improved diagnostic performance of a phage display antibody-assisted intact free PSA assay as used in the four kallikrein concept applied to the IMPROD/multi-IMPROD study (2025)

Time to abandon routine urine analysis prior to Bacillus Calmette–Guérin administration in asymptomatic patients (2025)

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer (2025)